Company / CapEx per Share
Charles River Laboratories CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$4.45
FY2025
5-year range
$2.82 / $4.54
FY2021-FY2025
Trend
-1.9%
vs FY2024
Sector context
#13 of 149
Health Care
What the data says
Among 149 Health Care companies, Charles River Laboratories is in the top 9% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $1.18 in FY2016 to $4.54 in FY2024.
Based on SEC 10-K filings.
4.45 in FY2025 with a 5-year CAGR of +9.2%. Top quartile in the Health Care sector.
Remained stable around $4.45 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +10.5%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 149This company $4.45 Sector average $1.68
▼
+165.6% above sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 1.9% year-over-year.
- Ranks #13 out of 149 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.45 | -1.9% |
| FY2024 | $4.54 | +1.1% |
| FY2023 | $4.49 | +36.1% |
| FY2022 | $3.30 | +16.9% |
| FY2021 | $2.82 | -1.3% |
| FY2020 | $2.86 | +67.4% |
| FY2019 | $1.71 | -42.1% |
| FY2018 | $2.95 | +69.8% |
| FY2017 | $1.74 | +47.0% |
| FY2016 | $1.18 | +43.1% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026